Literature DB >> 8929353

Osteoclast integrin alphaVbeta3 is present in the clear zone and contributes to cellular polarization.

I Nakamura1, J Gailit, T Sasaki.   

Abstract

Osteoclasts are primary bone-resorbing cells with highly polarized cytoplasmic structures, such as ruffled borders and clear zones. In the present study, we have examined the subcellular localization and function of the alphaVbeta3 integrin in primary rat osteoclasts and mouse osteoclast-like multinucleated cells (OCLs) formed in vitro. At the ultrastructural level, the specific immunoreactivity of both alphaV and beta3 subunits is localized not only along the plasma membranes of osteoclast ruffled borders and basolateral membranes but also in clear zones. Addition of GRGDS (Gly-Arg-Gly-Asp-Ser) peptide to the culture medium during a pit formation assay reduces resorbed areas on dentine slices in a dose-dependent manner. Treatment with the GRGDS peptide also dose-dependently inhibits the formation of a ringed structure of F-actin (an "actin ring") in OCLs on dentine slices. Electron-microscopic analysis has revealed that OCLs treated with GRGDS peptide at 1 mM can adhere to dentine slices with unusually broad or poorly defined clear zones but do not form the ruffled burder structure. These results suggest that integrin alphaV and beta3 subunits localized in the ruffled border/clear zone complex of osteoclasts are essential for the functional osteoclast-to-bone matrix interaction and the structural polarization of osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929353     DOI: 10.1007/s004410050720

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  9 in total

1.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.

Authors:  W He; B N Cronstein
Journal:  Purinergic Signal       Date:  2012-02-05       Impact factor: 3.765

2.  Parathyroid hormone-related protein induces spontaneous osteoclast formation via a paracrine cascade.

Authors:  I A Nakchbandi; E E Weir; K L Insogna; W M Philbrick; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Microscopic study on resorption of β-tricalcium phosphate materials by osteoclasts.

Authors:  Akihiro Matsunaga; Masamichi Takami; Tarou Irié; Kenji Mishima; Katsunori Inagaki; Ryutaro Kamijo
Journal:  Cytotechnology       Date:  2015-02-12       Impact factor: 2.058

4.  64Cu-Labeled Phosphonate Cross-Bridged Chelator Conjugates of c(RGDyK) for PET/CT Imaging of Osteolytic Bone Metastases.

Authors:  Meltem Ocak; Wissam Beaino; Alexander White; Dexing Zeng; Zhengxin Cai; Carolyn J Anderson
Journal:  Cancer Biother Radiopharm       Date:  2018-03       Impact factor: 3.099

5.  Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.

Authors:  M A Chellaiah; N Kizer; R Biswas; U Alvarez; J Strauss-Schoenberger; L Rifas; S R Rittling; D T Denhardt; K A Hruska
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

6.  A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.

Authors:  John F Harms; Danny R Welch; Rajeev S Samant; Lalita A Shevde; Mary E Miele; Geetha R Babu; Steven F Goldberg; Virginia R Gilman; Donna M Sosnowski; Dianalee A Campo; Carol V Gay; Lynn R Budgeon; Robin Mercer; Jennifer Jewell; Andrea M Mastro; Henry J Donahue; Nuray Erin; Michael T Debies; William J Meehan; Amy L Jones; Gabriel Mbalaviele; Allen Nickols; Neil D Christensen; Robert Melly; Lisa N Beck; Julia Kent; Randall K Rader; John J Kotyk; M D Pagel; William F Westlin; David W Griggs
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 7.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

8.  NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue.

Authors:  Angélica Rivera-Villaseñor; Frida Higinio-Rodríguez; Laura Nava-Gómez; Bárbara Vázquez-Prieto; Isnarhazni Calero-Vargas; Rafael Olivares-Moreno; Mónica López-Hidalgo
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

Review 9.  Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Toshifumi Sugatani
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.